“TRIAL READY (Clinical Trial Readiness)”
This study, being conducted under the auspice of the CReATe Consortium, will enroll patients with ALS and related disorders as well as healthy controls, with the goal of facilitating clinical validation of leading biological-fluid based biomarker candidates that may aid therapy development for patients with ALS and related disorders.
Methods have not been listed for this study. If you require more information about the methods of this study, please inquire with the researcher.
TRIAL READY (Clinical Trial Readiness)